These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. A Fluorescent Adenosine Analogue as a Substrate for an A-to-I RNA Editing Enzyme. Mizrahi RA; Shin D; Sinkeldam RW; Phelps KJ; Fin A; Tantillo DJ; Tor Y; Beal PA Angew Chem Int Ed Engl; 2015 Jul; 54(30):8713-6. PubMed ID: 26095193 [TBL] [Abstract][Full Text] [Related]
9. irCLASH reveals RNA substrates recognized by human ADARs. Song Y; Yang W; Fu Q; Wu L; Zhao X; Zhang Y; Zhang R Nat Struct Mol Biol; 2020 Apr; 27(4):351-362. PubMed ID: 32203492 [TBL] [Abstract][Full Text] [Related]
11. Adenosine Deaminases That Act on RNA (ADARs). Wang Y; Zheng Y; Beal PA Enzymes; 2017; 41():215-268. PubMed ID: 28601223 [TBL] [Abstract][Full Text] [Related]
12. Revealing Differential RNA Editing Specificity of Human ADAR1 and ADAR2 in Zhang N; Chen P; Cui Z; Zhou X; Hao C; Xie B; Hao P; Ye BC; Li X; Jing X Genes (Basel); 2024 Jul; 15(7):. PubMed ID: 39062677 [TBL] [Abstract][Full Text] [Related]
13. Mechanisms and implications of ADAR-mediated RNA editing in cancer. Wang C; Zou J; Ma X; Wang E; Peng G Cancer Lett; 2017 Dec; 411():27-34. PubMed ID: 28974449 [TBL] [Abstract][Full Text] [Related]
14. DNA editing in DNA/RNA hybrids by adenosine deaminases that act on RNA. Zheng Y; Lorenzo C; Beal PA Nucleic Acids Res; 2017 Apr; 45(6):3369-3377. PubMed ID: 28132026 [TBL] [Abstract][Full Text] [Related]
15. ICLAMP: a novel technique to explore adenosine deamination via inosine chemical labeling and affinity molecular purification. Yang Y; Nakayama K; Okada S; Sato K; Wada T; Sakaguchi Y; Murayama A; Suzuki T; Sakurai M FEBS Lett; 2024 May; 598(9):1080-1093. PubMed ID: 38523059 [TBL] [Abstract][Full Text] [Related]
16. Methods for recruiting endogenous and exogenous ADAR enzymes for site-specific RNA editing. Xiang Y; Katrekar D; Mali P Methods; 2022 Sep; 205():158-166. PubMed ID: 35779766 [TBL] [Abstract][Full Text] [Related]
17. Rewriting the transcriptome: adenosine-to-inosine RNA editing by ADARs. Walkley CR; Li JB Genome Biol; 2017 Oct; 18(1):205. PubMed ID: 29084589 [TBL] [Abstract][Full Text] [Related]
18. Noncoding regions of C. elegans mRNA undergo selective adenosine to inosine deamination and contain a small number of editing sites per transcript. Wheeler EC; Washburn MC; Major F; Rusch DB; Hundley HA RNA Biol; 2015; 12(2):162-74. PubMed ID: 25826568 [TBL] [Abstract][Full Text] [Related]
19. Nucleoside analogs in the study of the epitranscriptome. Palumbo CM; Beal PA Methods; 2019 Mar; 156():46-52. PubMed ID: 30827466 [TBL] [Abstract][Full Text] [Related]
20. ADAR activation by inducing a syn conformation at guanosine adjacent to an editing site. Doherty EE; Karki A; Wilcox XE; Mendoza HG; Manjunath A; Matos VJ; Fisher AJ; Beal PA Nucleic Acids Res; 2022 Oct; 50(19):10857-10868. PubMed ID: 36243986 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]